High Intensity Focused Ultrasound Therapy Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An augmented hybrid multibaseline and referenceless MR thermometry motion compensation algorithm for MRgHIFU hyperthermia
CONCLUSION: The PCA-PDF algorithm improved temperature accuracy to <1°C during periodic motion, but was not able to adequately address sporadic motion. By augmenting the PCA-PDF algorithm, temperature SD during large sporadic motion was also reduced to <1°C, greatly improving the original PCA-PDF algorithm.PMID:38181187 | DOI:10.1002/mrm.29988 (Source: Magnetic Resonance in Medicine)
Source: Magnetic Resonance in Medicine - January 5, 2024 Category: Radiology Authors: Suzanne M Wong Arthur Akbulatov Craig A Macsemchuk Andrew Headrick Phoebe Luo James M Drake Adam C Waspe Source Type: research

Cancers, Vol. 16, Pages 236: Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood & ndash;Brain Barrier Disruption
Cancers, Vol. 16, Pages 236: Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood–Brain Barrier Disruption Cancers doi: 10.3390/cancers16010236 Authors: Miłosz Pinkiewicz Mateusz Pinkiewicz Jerzy Walecki Artur Zaczyński Michał Zawadzki The blood&ndash;brain barrier (BBB) poses a significant challenge to drug delivery for brain tumors, with most chemotherapeutics having limited permeability into non-malignant brain tissue and only restricted access to primary and metastatic brain cancers. Consequently, due to the drug&...
Source: Cancers - January 4, 2024 Category: Cancer & Oncology Authors: Mi łosz Pinkiewicz Mateusz Pinkiewicz Jerzy Walecki Artur Zaczy ński Micha ł Zawadzki Tags: Systematic Review Source Type: research

In vitro investigation of the effects of high-intensity therapeutic ultrasound (HITU) in glial tumor cell culture
CONCLUSIONS: Our laboratory analyses offer compelling evidence that HITU is not merely feasible but is also a promising non-invasive approach in the treatment paradigm of brain tumors. Standing distinctively apart from radiotherapy, HITU averts early, or late complications commonly associated with the former. While the path ahead mandates comprehensive research to ascertain its clinical utility, preliminary indications firmly posit HITU as a groundbreaking prospect in the management of brain tumors.PMID:38164850 | DOI:10.26355/eurrev_202312_34785 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - January 2, 2024 Category: Drugs & Pharmacology Authors: K T Ozdemir G Ayberk A Kazanci E Simsek C Kabakci Source Type: research

Long-term outcome and risk factors of reintervention after high intensity focused ultrasound ablation for uterine fibroids: a systematic review and meta-analysis
CONCLUSION: This meta-analysis showed that the overall reintervention rates after HIFU were acceptable and provided consultative suggestions regarding treatment alternatives for patients with fibroids. Subgroup-analysis revealed that USgHIFU, NPVR ≥ 50%, and hypo-/iso-intensity of fibroids on T2WI were significant factors in reducing reintervention.SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42023456094.PMID:38164630 | DOI:10.1080/02656736.2023.2299479 (Source: International Journal of Hyperthermia)
Source: International Journal of Hyperthermia - January 2, 2024 Category: Internal Medicine Authors: Yuya Dou Lian Zhang Yu Liu Min He Yanzhou Wang Zhibiao Wang Source Type: research

In vitro investigation of the effects of high-intensity therapeutic ultrasound (HITU) in glial tumor cell culture
CONCLUSIONS: Our laboratory analyses offer compelling evidence that HITU is not merely feasible but is also a promising non-invasive approach in the treatment paradigm of brain tumors. Standing distinctively apart from radiotherapy, HITU averts early, or late complications commonly associated with the former. While the path ahead mandates comprehensive research to ascertain its clinical utility, preliminary indications firmly posit HITU as a groundbreaking prospect in the management of brain tumors.PMID:38164850 | DOI:10.26355/eurrev_202312_34785 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - January 2, 2024 Category: Drugs & Pharmacology Authors: K T Ozdemir G Ayberk A Kazanci E Simsek C Kabakci Source Type: research